185 related articles for article (PubMed ID: 19350684)
1. Concurrent blockade of alpha4-integrin and CXCR4 in hematopoietic stem/progenitor cell mobilization.
Bonig H; Watts KL; Chang KH; Kiem HP; Papayannopoulou T
Stem Cells; 2009 Apr; 27(4):836-7. PubMed ID: 19350684
[TBL] [Abstract][Full Text] [Related]
2. Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26-/- mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis.
Paganessi LA; Walker AL; Tan LL; Holmes I; Rich E; Fung HC; Christopherson KW
Exp Hematol; 2011 Mar; 39(3):384-90. PubMed ID: 21168468
[TBL] [Abstract][Full Text] [Related]
3. Progenitor cell mobilization and recruitment: SDF-1, CXCR4, α4-integrin, and c-kit.
Cheng M; Qin G
Prog Mol Biol Transl Sci; 2012; 111():243-64. PubMed ID: 22917234
[TBL] [Abstract][Full Text] [Related]
4. BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells.
Ramirez P; Rettig MP; Uy GL; Deych E; Holt MS; Ritchey JK; DiPersio JF
Blood; 2009 Aug; 114(7):1340-3. PubMed ID: 19571319
[TBL] [Abstract][Full Text] [Related]
5. AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.
Larochelle A; Krouse A; Metzger M; Orlic D; Donahue RE; Fricker S; Bridger G; Dunbar CE; Hematti P
Blood; 2006 May; 107(9):3772-8. PubMed ID: 16439684
[TBL] [Abstract][Full Text] [Related]
6. Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil™) and potential of other CXCR4 antagonists as stem cell mobilizers.
De Clercq E
Pharmacol Ther; 2010 Dec; 128(3):509-18. PubMed ID: 20826182
[TBL] [Abstract][Full Text] [Related]
7. Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells.
Pusic I; DiPersio JF
Curr Opin Hematol; 2010 Jul; 17(4):319-26. PubMed ID: 20473162
[TBL] [Abstract][Full Text] [Related]
8. Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells.
Dar A; Schajnovitz A; Lapid K; Kalinkovich A; Itkin T; Ludin A; Kao WM; Battista M; Tesio M; Kollet O; Cohen NN; Margalit R; Buss EC; Baleux F; Oishi S; Fujii N; Larochelle A; Dunbar CE; Broxmeyer HE; Frenette PS; Lapidot T
Leukemia; 2011 Aug; 25(8):1286-1296. PubMed ID: 21494253
[TBL] [Abstract][Full Text] [Related]
9. Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells.
Uy GL; Rettig MP; Cashen AF
Expert Opin Biol Ther; 2008 Nov; 8(11):1797-804. PubMed ID: 18847313
[TBL] [Abstract][Full Text] [Related]
10. Small molecule Me6TREN mobilizes hematopoietic stem/progenitor cells by activating MMP-9 expression and disrupting SDF-1/CXCR4 axis.
Zhang J; Ren X; Shi W; Wang S; Chen H; Zhang B; Wang Z; Zhou Y; Chen L; Zhang R; Lv Y; Zhou J; Nan X; He L; Yue W; Li Y; Pei X
Blood; 2014 Jan; 123(3):428-41. PubMed ID: 24196072
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice.
Juarez JG; Harun N; Thien M; Welschinger R; Baraz R; Pena AD; Pitson SM; Rettig M; DiPersio JF; Bradstock KF; Bendall LJ
Blood; 2012 Jan; 119(3):707-16. PubMed ID: 22049516
[TBL] [Abstract][Full Text] [Related]
12. AMD3100: CXCR4 antagonist and rapid stem cell-mobilizing agent.
Cashen AF; Nervi B; DiPersio J
Future Oncol; 2007 Feb; 3(1):19-27. PubMed ID: 17280498
[TBL] [Abstract][Full Text] [Related]
13. Synergistic mobilization of hemopoietic progenitor cells using concurrent beta1 and beta2 integrin blockade or beta2-deficient mice.
Papayannopoulou T; Priestley GV; Nakamoto B; Zafiropoulos V; Scott LM; Harlan JM
Blood; 2001 Mar; 97(5):1282-8. PubMed ID: 11222371
[TBL] [Abstract][Full Text] [Related]
14. Insights into the biology of mobilized hematopoietic stem/progenitor cells through innovative treatment schedules of the CXCR4 antagonist AMD3100.
Bonig H; Chudziak D; Priestley G; Papayannopoulou T
Exp Hematol; 2009 Mar; 37(3):402-15.e1. PubMed ID: 19157683
[TBL] [Abstract][Full Text] [Related]
15. Adult stem cell mobilization enhances intramembranous bone regeneration: a pilot study.
McNulty MA; Virdi AS; Christopherson KW; Sena K; Frank RR; Sumner DR
Clin Orthop Relat Res; 2012 Sep; 470(9):2503-12. PubMed ID: 22528386
[TBL] [Abstract][Full Text] [Related]
16. The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil).
De Clercq E
Biochem Pharmacol; 2009 Jun; 77(11):1655-64. PubMed ID: 19161986
[TBL] [Abstract][Full Text] [Related]
17. Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cells.
Flomenberg N; DiPersio J; Calandra G
Acta Haematol; 2005; 114(4):198-205. PubMed ID: 16269859
[TBL] [Abstract][Full Text] [Related]
18. Structural analogues of AMD3100 mobilise haematopoietic progenitor cells from bone marrow in vivo according to their ability to inhibit CXCL12 binding to CXCR4 in vitro.
Martin C; Bridger GJ; Rankin SM
Br J Haematol; 2006 Aug; 134(3):326-9. PubMed ID: 16787495
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo expansion of hematopoietic progenitor cells is associated with downregulation of alpha4 integrin- and CXCR4-mediated engraftment in NOD/SCID beta2-microglobulin-null mice.
Foguenne J; Di Stefano I; Giet O; Beguin Y; Gothot A
Haematologica; 2009 Feb; 94(2):185-94. PubMed ID: 19144663
[TBL] [Abstract][Full Text] [Related]
20. SDF-1/CXCR4 blockade to mobilize hematopoietic progenitor cells from the placenta.
Jing D; Alakel N; Bornhäuser M; Ehninger G; Ordemann R
Bone Marrow Transplant; 2010 Nov; 45(11):1661-2. PubMed ID: 20173795
[No Abstract] [Full Text] [Related]
[Next] [New Search]
